{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:07:38Z","timestamp":1749182858052,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10067-025-07428-6","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T04:01:58Z","timestamp":1744603318000},"page":"2355-2365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary\u00a0Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"44","author":[{"given":"Chenchen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-6250","authenticated-orcid":false,"given":"Shasha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"7428_CR1","doi-asserted-by":"publisher","first-page":"854183","DOI":"10.3389\/fimmu.2022.854183","volume":"13","author":"I Sarkar","year":"2022","unstructured":"Sarkar I (2022) Aberrant signaling of immune cells in Sj\u00f6gren\u2019s syndrome patient subgroups upon interferon stimulation. Front Immunol 13:854183","journal-title":"Front Immunol"},{"key":"7428_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366:321\u2013331","journal-title":"Lancet"},{"key":"7428_CR3","doi-asserted-by":"publisher","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 9:A305\u2013A310","journal-title":"Autoimmun Rev"},{"key":"7428_CR4","doi-asserted-by":"publisher","first-page":"5928232","DOI":"10.1155\/2021\/5928232","volume":"2021","author":"Y Tian","year":"2021","unstructured":"Tian Y, Yang H, Liu N, Li Y, Chen J (2021) Advances in pathogenesis of Sj\u00f6gren\u2019s syndrome. J Immunol Res 2021:5928232","journal-title":"J Immunol Res"},{"key":"7428_CR5","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3390\/ijms22063090","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Nakamura H, Kawakami A (2021) Role of the innate immunity signaling pathway in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 22:3090","journal-title":"Int J Mol Sci"},{"key":"7428_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M (2022) Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med 22:9\u201325","journal-title":"Clin Exp Med"},{"key":"7428_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","volume":"4","author":"C Selmi","year":"2017","unstructured":"Selmi C, Gershwin ME (2017) Chronic autoimmune epithelitis in Sj\u00f6gren\u2019s syndrome and primary biliary cholangitis: a comprehensive review. Rheumatol Ther 4:263\u2013279","journal-title":"Rheumatol Ther"},{"key":"7428_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/ijms22020658","volume":"22","author":"C Chivasso","year":"2021","unstructured":"Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo MS (2021) The involvement of innate and adaptive immunity in the initiation and perpetuation of Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 22:658","journal-title":"Int J Mol Sci"},{"key":"7428_CR9","doi-asserted-by":"publisher","first-page":"1127417","DOI":"10.3389\/fimmu.2023.1127417","volume":"14","author":"Q Zhan","year":"2023","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D et al (2023) Pathogenesis and treatment of Sjogren\u2019s syndrome: review and update. Front Immunol 14:1127417","journal-title":"Front Immunol"},{"key":"7428_CR10","doi-asserted-by":"publisher","first-page":"684999","DOI":"10.3389\/fimmu.2021.684999","volume":"12","author":"W Du","year":"2021","unstructured":"Du W (2021) The multiple roles of B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Front Immunol 12:684999","journal-title":"Front Immunol"},{"key":"7428_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cbin.11236","volume":"44","author":"L Ye","year":"2020","unstructured":"Ye L, Shi H, Wu S, Yu C, Wang B, Zheng L et al (2020) Dysregulated interleukin 11 in primary Sj\u00f6gren\u2019s syndrome contributes to apoptosis of glandular epithelial cells. Cell Biol Int 44:327\u2013335","journal-title":"Cell Biol Int"},{"key":"7428_CR12","doi-asserted-by":"crossref","unstructured":"Jonsson R, Brokstad KA, Jonsson MV, Delaleu N, Skarstein K (2018) Current concepts on Sj\u00f6gren\u2019s syndrome-classification criteria and biomarkers. Eur J Oral Sci\u00a0 126 Suppl 1(Suppl Suppl 1):37\u201348","DOI":"10.1111\/eos.12536"},{"key":"7428_CR13","unstructured":"Shao Q, Jin L, Wu B et al (2021) Comparative analysis of the efficacy and safety of herbal decoction CheReCunJin alone and combined with hydroxychloroquine for treating primary Sj\u00f6gren\u2019s syndrome: a randomized controlled trial. EXPLORE J Sci Heal 7:1\u20137"},{"key":"7428_CR14","doi-asserted-by":"crossref","unstructured":"Horvath S (2012) Systems analysis of primary Sj\u00f6gren\u2019s syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Res Ther 14:R238","DOI":"10.1186\/ar4081"},{"issue":"1","key":"7428_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS (2022Feb) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25\u201336","journal-title":"Korean J Anesthesiol"},{"key":"7428_CR16","doi-asserted-by":"crossref","unstructured":"Mestermann K, Giavridis T, Weber J, Rydzek J, Frenz S, Nerreter T et al (2019) The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells. Sci Transl Med 11(499):eaau5907","DOI":"10.1126\/scitranslmed.aau5907"},{"issue":"1","key":"7428_CR17","doi-asserted-by":"publisher","first-page":"2131751","DOI":"10.1080\/09537104.2022.2131751","volume":"34","author":"N Cooper","year":"2023","unstructured":"Cooper N, Ghanima W, Hill QA, Nicolson PL, Markovtsov V, Kessler C (2023Dec) Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib. Platelets 34(1):2131751","journal-title":"Platelets"},{"issue":"12","key":"7428_CR18","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1093\/rheumatology\/keac167","volume":"61","author":"E Price","year":"2022","unstructured":"Price E, Bombardieri M, Kivitz A, Matzkies F, Gurtovaya O, Pechonkina A et al (2022Nov 28) Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sj\u00f6gren\u2019s syndrome: a randomized, phase 2, double-blind, placebo-controlled study. Rheumatology (Oxford) 61(12):4797\u20134808","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Suppl","key":"7428_CR19","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/mjd.2003.552","volume":"49","author":"GG Krueger","year":"2003","unstructured":"Krueger GG, Callis KP (2003Aug) Development and use of alefacept to treat psoriasis. J Am Acad Dermatol 49(2 Suppl):S87-97","journal-title":"J Am Acad Dermatol"},{"key":"7428_CR20","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.phrs.2024.107059","volume":"200","author":"R Roskoski Jr","year":"2024","unstructured":"Roskoski R Jr (2024Feb) Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update. Pharmacol Res 200:107059","journal-title":"Pharmacol Res"},{"issue":"8","key":"7428_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s40265-024-02063-y","volume":"84","author":"SM Hoy","year":"2024","unstructured":"Hoy SM (2024Aug) Mavorixafor: first approval. Drugs 84(8):969\u2013975","journal-title":"Drugs"},{"key":"7428_CR22","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.phrs.2020.105010","volume":"159","author":"J Wang","year":"2020","unstructured":"Wang J, Tannous BA, Poznansky MC, Chen H (2020Sep) CXCR4 antagonist AMD3100 (plerixafor): from an impurity to a therapeutic agent. Pharmacol Res 159:105010","journal-title":"Pharmacol Res"},{"issue":"17","key":"7428_CR23","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s40265-023-01962-w","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy SM (2023Nov) Motixafortide: first approval. Drugs 83(17):1635\u20131643","journal-title":"Drugs"},{"issue":"2","key":"7428_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/sji.12079","volume":"78","author":"A Karabiyik","year":"2013","unstructured":"Karabiyik A, Peck AB, Nguyen CQ (2013Aug) The important role of T cells and receptor expression in Sj\u00f6gren\u2019s syndrome. Scand J Immunol 78(2):157\u2013166","journal-title":"Scand J Immunol"},{"issue":"15","key":"7428_CR25","doi-asserted-by":"publisher","first-page":"1345381","DOI":"10.3389\/fimmu.2024.1345381","volume":"26","author":"J Liao","year":"2024","unstructured":"Liao J, Yu X, Huang Z, He Q, Yang J, Zhang Y et al (2024Apr) Chemokines and lymphocyte homing in Sj\u00f6gren\u2019s syndrome. Front Immunol 26(15):1345381","journal-title":"Front Immunol"},{"issue":"5","key":"7428_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","volume":"31","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska M (2019Sep) The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol 31(5):475\u2013483","journal-title":"Curr Opin Rheumatol"},{"key":"7428_CR27","unstructured":"Gerli R, Bertotto A, Cernetti C, Agea E, Crupi S, Arcangeli C, Spinozzi F, Galandrini R, Rambotti P (1989) Anti-CD3 and anti-CD2-induced T-cell activation in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 7 Suppl 3:S129\u201334"},{"issue":"12","key":"7428_CR28","doi-asserted-by":"publisher","first-page":"697157","DOI":"10.3389\/fimmu.2021.697157","volume":"23","author":"N Li","year":"2021","unstructured":"Li N, Li L, Wu M, Li Y, Yang J, Wu Y et al (2021Jul) Integrated bioinformatics and validation reveal potential biomarkers associated with progression of primary Sj\u00f6gren\u2019s syndrome. Front Immunol 23(12):697157","journal-title":"Front Immunol"},{"issue":"141","key":"7428_CR29","doi-asserted-by":"publisher","first-page":"112899","DOI":"10.1016\/j.intimp.2024.112899","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Wang Q, Zhao K, Zhang S, Chen Z (2024Nov) Exploration of the shared diagnostic genes and mechanisms between periodontitis and primary Sj\u00f6gren\u2019s syndrome by integrated comprehensive bioinformatics analysis and machine learning. Int Immunopharmacol 15(141):112899","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7428_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/ecn.2024.0496","volume":"35","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Liu X, Ganesan K, Shi G (2024Feb 1) Identification of inflammatory markers as indicators for disease progression in primary Sj\u00f6gren syndrome. Eur Cytokine Netw 35(1):1\u201312","journal-title":"Eur Cytokine Netw"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07428-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:21:02Z","timestamp":1749129662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7428"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07428-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}